Omnia SanaPlant Comparison
Astragalus vs Blue gum eucalyptus
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Astragalus and Blue gum eucalyptus: they share 6 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Astragalus | Blue gum eucalyptus | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 2/10 | Comparable evidence |
| Cold & flu | 2/10 | 2/10 | Comparable evidence |
| Immune support | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Major bioactive saponin with cardio-, neuro-, hepato- and renoprotective effects.
Leaf essential oil dominated by 1,8-cineole (eucalyptol, typically 70%+), the principal compound responsible for the plant's antimicrobial, anti-inflammatory and expectorant/decongestant activity.
Pharmacological Actions
Astragalus membranaceus and its constituents (astragaloside IV, cycloastragenol, Astragalus polysaccharide) inhibit tumour growth, invasion and metastasis and enhance antitumour immunity across lung, colorectal and gastrointestinal cancers (preclinical, incl. in vivo).
Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Astragalus membranaceus protects against gastrointestinal cancers; astragaloside IV inhibits lung cancer metastasis via macrophage repolarization, cycloastragenol boosts CD8+ T-cell antitumour immunity (with anti-PD-1 synergy), and Astragalus polysaccharide suppresses inflammation-induced colorectal cancer (preclinical).
Supports resistance to colds and respiratory infection (immune)
Adaptogenic tonic for fatigue and low vitality (traditional 'Qi' tonic)
Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes); Supports resistance to colds and respiratory infection (immune)
Supports resistance to colds and respiratory infection (immune)
inferred from anti-inflammatory action
Renoprotective (kidney support) - as an adjunct in chronic kidney disease, reduced proteinuria and raised haemoglobin and serum albumin across trials (Cochrane review; study quality low)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Astragalus stimulates immune activity; on theoretical grounds it should be used cautiously in autoimmune disease and with immunosuppressant medicines (for example after organ transplant) - discuss with a clinician.
Generally well tolerated; high-quality long-term human safety and toxicity data remain limited.
Safety in pregnancy and breastfeeding has not been established; avoid medicinal doses.
Eucalyptus globulus essential oil is highly concentrated and rich in the monoterpene 1,8-cineole; it should never be applied undiluted to the skin or ingested outside of standardized pharmaceutical preparations. Improper use can cause irritation, nausea, dizziness, or neurological symptoms, and inhalation at high concentrations may provoke respiratory distress, particularly in infants, young children, or individuals with asthma or other airway sensitivities. For this reason, essential oil use is generally discouraged in children and during pregnancy unless under professional guidance. Preparations such as leaf-infused oils or external applications using whole plant material are considerably milder, but they should still be used with care and an understanding that different preparation methods carry different levels of risk.
Duke (2002) provides clinical evidence (score 2) for eucalyptus as an expectorant and topical hyperemic (rubefacient), consistent with Commission E approval. Clinical evidence also supports its use in asthma, bronchitis, and catarrh. The essential oil (primarily 1,8-cineole) is the active constituent. Therapeutic use as steam inhalation is well-established. Internal use of the essential oil at high doses is contraindicated due to toxicity; even small amounts (3.5 ml) can be fatal in children. Contraindicated for inflammatory diseases of the gastrointestinal tract or bile ducts (Duke, 2002).
External Ids
Botanical Description
Erect perennial herb with a long, fibrous, pale yellow taproot. The leaves are pinnately compound with numerous small, oval leaflets, giving a soft, ferny appearance. Small, pale yellow, pea-like flowers are borne in loose axillary clusters (racemes), followed by membranous, inflated seed pods that give the species its name.[5]
Large, fast-growing evergreen tree with distinctive two-stage leaves: rounded, silvery-blue juvenile leaves borne in opposite pairs, giving way to narrow, sickle-shaped, aromatic, dark green mature leaves as the tree ages. Small, cream-white, fluffy flowers with numerous stamens are borne singly or in small clusters, followed by a woody, cup-shaped seed capsule ('gum nut').[12]
Habitat
Native to the grasslands, sunny slopes and forest margins of northern and north-eastern China, Mongolia and parts of Korea; widely cultivated as a medicinal crop across East Asia.[5]
Native to south-eastern Australia and Tasmania; widely planted worldwide in warm-temperate and Mediterranean climates for timber, essential oil production and as an ornamental/windbreak tree.
Harvesting
The root is dug from plants at least four years old, typically in spring or autumn, then cleaned and dried, often sliced into the characteristic pale, fibrous 'coin' slices used in traditional decoctions.[5]
Mature leaves are picked or pruned year-round and used fresh, dried, or steam-distilled for essential oil, which is the main commercial and medicinal form.
Traditional Uses
Eucalyptus leaf has a long Australian Aboriginal and, after global spread, worldwide tradition as a respiratory remedy - inhaled as steam or applied as chest rubs for colds, coughs, bronchitis and catarrh - and as a topical antiseptic and rubefacient for minor wounds and muscular aches.[12]
Preparations
A few drops of essential oil, or fresh/dried leaf, added to hot water and the vapour inhaled for respiratory congestion; the classic and best-established use.
Diluted essential oil in a carrier oil or standardised ointment applied to the chest and back for coughs and colds.
Comminuted dried leaf infused in 150 ml boiling water, 1.5-3 g up to four times daily (daily dose 4.5-12 g) for oral use per the EU herbal monograph. Educational reference only, not a prescription.
Dosage
The WHO monograph on Radix Astragali gives doses of 3-9 g per day. Traditional Chinese medicine references often cite a considerably higher 9-30 g of dried root per day; WHO's figure is the conservative regulatory-tier one and is stated here in preference. Educational reference only, not a prescription.
Clinical studies commonly use extracts providing the equivalent of several grams of dried root daily, in divided doses. Educational reference only, not a prescription.
The EU herbal monograph on eucalyptus LEAF gives, for inhalation, 3 g of the comminuted leaf in boiling water up to 3 times daily (daily dose 3-9 g), and for oral use 1.5-3 g in 150 mL as an infusion up to 4 times daily (daily dose 4.5-12 g), in adolescents, adults and elderly. Use is CONTRAINDICATED in children under 30 months, and not recommended under 12 years. The essential oil is a separate herbal substance with its own monograph and its own posology - it is never taken internally or applied undiluted to skin on the strength of these leaf figures. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Xu, B., Huang, J.P., Peng, G., Cao, W., Liu, Z. et al (2024) 'Total biosynthesis of the medicinal triterpenoid saponin astragalosides', Nature Plants, 10(11), pp. 1826-1837. doi:10.1038/s41477-024-01827-4 Preclinical
https://doi.org/10.1038/s41477-024-01827-4 - Auyeung, K.K., Han, Q.B. and Ko, J.K (2016) 'Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers', The American Journal of Chinese Medicine, 44(1), pp. 1-22. doi:10.1142/S0192415X16500014 Traditional / reference
https://doi.org/10.1142/S0192415X16500014 - Zhang, Y., Ji, W., Qin, H., Chen, Z., Zhou, Y. et al (2024) 'Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent manner', Carbohydrate Polymers, 349, pp. 122829. doi:10.1016/j.carbpol.2024.122829 Preclinical
https://doi.org/10.1016/j.carbpol.2024.122829 - Fu, J., Wang, Z., Huang, L., Zheng, S., Wang, D., Chen, S., Zhang, H. and Yang, S (2014) 'Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)', Phytotherapy Research, 28(9), pp. 1275-1283. doi:10.1002/ptr.5188 Meta-analysis / review
https://doi.org/10.1002/ptr.5188 - Zhang, J., Wu, C., Gao, L., Du, G. and Qin, X (2019) 'Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects', Advances in Pharmacology. doi:10.1016/bs.apha.2019.08.002 Traditional / reference
https://doi.org/10.1016/bs.apha.2019.08.002 - Dong, M., Li, J., Yang, D., Li, M. and Wei, J (2023) 'Biosynthesis and pharmacological activities of flavonoids, triterpene saponins and polysaccharides derived from Astragalus membranaceus', Molecules, 28(13), pp. 5018. doi:10.3390/molecules28135018 Meta-analysis / review
https://doi.org/10.3390/molecules28135018 - Chen, G., Jiang, N., Zheng, J., Hu, H., Yang, H., Lin, A., Hu, B. and Liu, H (2023) 'Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 241, pp. 124386. doi:10.1016/j.ijbiomac.2023.124386 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.124386 - Zheng, Q., Zhuang, Z., Wang, Z., Deng, L., Jin, W., Huang, Z., Zheng, G. and Wang, Y (2020) 'Clinical and preclinical systematic review of Astragalus membranaceus for viral myocarditis', Oxidative Medicine and Cellular Longevity, 2020, pp. 1560353. doi:10.1155/2020/1560353 Meta-analysis / review
https://doi.org/10.1155/2020/1560353 - Dai, Y., Wang, Y., Kang, Q., Wu, Y., Liu, Y., Su, Y., Wang, X., Xiu, M. and He, J (2024) 'The protective effect and bioactive compounds of Astragalus membranaceus against neurodegenerative disorders via alleviating oxidative stress in Drosophila', FASEB Journal, 38(13), pp. e23727. doi:10.1096/fj.202400390R Preclinical
https://doi.org/10.1096/fj.202400390R - Xu, L., Xu, X., Hou, X., Wang, F., Gao, S. and Zhang, H (2019) 'Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review', Metabolic Brain Disease, 35(1), pp. 83-93. doi:10.1007/s11011-019-00483-4 Meta-analysis / review
https://doi.org/10.1007/s11011-019-00483-4 - Li, C.X., Liu, Y., Zhang, Y.Z., Li, J.C. and Lai, J (2022) 'Astragalus polysaccharide: a review of its immunomodulatory effect', Archives of Pharmacal Research. doi:10.1007/s12272-022-01393-3 Preclinical
https://doi.org/10.1007/s12272-022-01393-3 - Jin, M., Zhao, K., Huang, Q. and Shang, P (2014) 'Structural features and biological activities of the polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 64, pp. 257-266. doi:10.1016/j.ijbiomac.2013.12.002 Preclinical
https://doi.org/10.1016/j.ijbiomac.2013.12.002 - Liu, Y. and Lv, W (2019) 'Research progress in Astragalus membranaceus and its active components on immune responses in liver fibrosis', Chinese Journal of Integrative Medicine, 26(10), pp. 794-800. doi:10.1007/s11655-019-3039-1 Meta-analysis / review
https://doi.org/10.1007/s11655-019-3039-1 - World Health Organization (1999) 'Radix Astragali'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Xu, F. and Cui, W.-Q. and Wei, Y. and Cui, J. and Qiu, J. and Hu, L.-L. and Gong, W.-Y. and Dong, J.-C. and Liu, B.-J (2018) 'Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling', Journal of Experimental & Clinical Cancer Research, 37(1), pp. 207. doi:10.1186/s13046-018-0878-0 Preclinical
https://doi.org/10.1186/s13046-018-0878-0 - Deng, G. and Zhou, L. and Wang, B. and Sun, X. and Zhang, Q. and Chen, H. and Wan, N. and Ye, H. and Wu, X. and Sun, D. and Sun, Y. and Cheng, H (2022) 'Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation', Journal for ImmunoTherapy of Cancer, 10(10), pp. e004874. doi:10.1136/jitc-2022-004874 Preclinical
https://doi.org/10.1136/jitc-2022-004874 - Li, Q. and Zhang, C. and Xu, G. and Shang, X. and Nan, X. and Li, Y. and Liu, J. and Hong, Y. and Wang, Q. and Peng, G (2024) 'Astragalus polysaccharide ameliorates CD8 T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation-induced colorectal cancer', Biomedicine & Pharmacotherapy, 171, pp. 116172. doi:10.1016/j.biopha.2024.116172 Preclinical
https://doi.org/10.1016/j.biopha.2024.116172 - Zhang, H.W., Lin, Z.X., Xu, C., Leung, C. and Chan, L.S (2014) 'Astragalus (a traditional Chinese medicine) for treating chronic kidney disease', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008369.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD008369.pub2
- Čmiková, N., Galovičová, L., Schwarzová, M., Vukic, M.D. et al (2023) 'Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil', Plants (Basel), 12(5), pp. 1076. doi:10.3390/plants12051076 Preclinical
https://doi.org/10.3390/plants12051076 - Elangovan, S. and Mudgil, P (2023) 'Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review', Antibiotics (Basel), 12(3), pp. 474. doi:10.3390/antibiotics12030474 Meta-analysis / review
https://doi.org/10.3390/antibiotics12030474 - Zonfrillo, M., Andreola, F., Krasnowska, E.K., Sferrazza, G. et al (2022) 'Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages', Molecules, 27(11), pp. 3488. doi:10.3390/molecules27113488 Preclinical
https://doi.org/10.3390/molecules27113488 - Arooj, B., Asghar, S., Saleem, M., Khalid, S.H., Asif, M., Chohan, T., Khan, I.U., Zubair, H.M. and Yaseen, H.S (2023) 'Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofen', Inflammopharmacology, 31(4), pp. 1849-1862. doi:10.1007/s10787-023-01237-6 Preclinical
https://doi.org/10.1007/s10787-023-01237-6 - Assaggaf, H.M., Naceiri Mrabti, H., Rajab, B.S., Attar, A.A., Hamed, M., Sheikh, R.A., Omari, N.E., Menyiy, N.E., Belmehdi, O., Mahmud, S., Alshahrani, M.M., Park, M.N., Kim, B., Zengin, G. and Bouyahya, A (2022) 'Singular and Combined Effects of Essential Oil and Honey of Eucalyptus globulus on Anti-Inflammatory, Antioxidant, Dermatoprotective, and Antimicrobial Properties: In Vitro and In Vivo Findings', Molecules, 27(16), pp. 5121. doi:10.3390/molecules27165121 Preclinical
https://doi.org/10.3390/molecules27165121 - Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J. and Wink, M (2010) 'Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens', Phytomedicine, 17(13), pp. 1061-1066. doi:10.1016/j.phymed.2010.06.018 Preclinical
https://doi.org/10.1016/j.phymed.2010.06.018 - Luis, A., Neiva, D., Pereira, H., Gominho, J., Domingues, F. and Duarte, A.P (2014) 'Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols', Molecules, 19(10), pp. 16428-16446. doi:10.3390/molecules191016428 Preclinical
https://doi.org/10.3390/molecules191016428 - Merghni, A., Noumi, E., Hadded, O., Dridi, N., Panwar, H., Ceylan, O., Mastouri, M. and Snoussi, M (2018) 'Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains', Microbial Pathogenesis, 118, pp. 74-80. doi:10.1016/j.micpath.2018.03.006 Preclinical
https://doi.org/10.1016/j.micpath.2018.03.006 - Mousa, A.A., Elweza, A.E., Elbaz, H.T., Tahoun, E.A.E., Shoghy, K.M., Elsayed, I. and Hassan, E.B (2019) 'Eucalyptus Globulus protects against diclofenac sodium induced hepatorenal and testicular toxicity in male rats', Journal of Traditional and Complementary Medicine, 10(6), pp. 521-528. doi:10.1016/j.jtcme.2019.11.002 Preclinical
https://doi.org/10.1016/j.jtcme.2019.11.002 - Mota, V.S., Turrini, R.N.T. and Poveda, V.B (2015) 'Antimicrobial activity of Eucalyptus globulus oil, xylitol and papain: a pilot study', Revista da Escola de Enfermagem da USP, 49(2), pp. 216-220. doi:10.1590/S0080-623420150000200005 Preclinical
https://doi.org/10.1590/S0080-623420150000200005 - Nguyen, H.T.T., Miyamoto, A., Nguyen, H.T., Pham, H.T., Hoang, H.T., Tong, N.T.M., Truong, L.T.N. and Nguyen, H.T.T (2023) 'Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves - the involvements of major constituents', PLoS One, 18(7), pp. e0288787. doi:10.1371/journal.pone.0288787 Preclinical
https://doi.org/10.1371/journal.pone.0288787 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Eucalyptus globulus Labill., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf - Sadlon, A.E. and Lamson, D.W (2010) 'Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices', 15(1), pp. 33--47. Preclinical
https://scholar.google.com/scholar?q=Immune-modifying%20and%20antimicrobial%20effects%20of%20Eucalyptus%20oil%20and%20simple%20inhalation%20devices - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.